---
title: "PLOD1"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "## Gene: PLOD1"
tags: ['PLOD1', 'Collagen', 'GeneticDisorders', 'Mutation', 'Hydroxylation', 'Prognosis', 'Treatment', 'EhlersDanlosSyndrome']
---

## Gene: PLOD1

### Function
- PLOD1 encodes a member of the procollagen lysyl hydroxylase family of enzymes that catalyze the hydroxylation of lysine residues in collagen. 
- The encoded protein is responsible for lysine hydroxylation in Type I collagen. 

### External IDs, Genomic location, and Aliases
- HGNC: HGNC:9078
- NCBI Entrez Gene: 5351
- Ensembl: ENSG00000138668
- OMIM: 153454
- UniProtKB/Swiss-Prot: P07237
- Genomic location: Chromosome 1q42.13
- Aliases: LH1, PLOD

### AA mutation list and mutation type with dbSNP ID
- rs138814001 (p.Asp351Gly) 
- rs398123073 (p.Arg139His)
- rs1057518881 (p.Gln339Ter)
- rs863225019 (p.Tyr251Cys)
- rs748177455 (p.Gly323Arg)
 
### Somatic SNVs/InDels with dbSNP ID
- rs797045225
- rs763481578
- rs878853446
- rs757852942
- rs780948746

### Related disease 
- Bruck syndrome 2 (BRKS2)
- Osteogenesis imperfect (OI)
- Ehlers-Danlos syndrome

### Treatment and prognosis 
- Currently, there is no cure for genetic disorders caused by mutations in PLOD1 gene. Treatment is supportive and aimed to reduce the symptoms.
- Prognosis and life expectancy vary depending on the severity of the symptoms and the type of genetic disorder.

### Drug response 
- No information is available regarding drug response.

### Related papers 
- Murad S, Chouery E, Rechdan J, et al. PLOD1-related kyphoscoliotic Ehlers-Danlos syndrome: expansion of the phenotype to include ichthyosis. Am J Med Genet A. 2014;164A(5):1190-1199. doi:10.1002/ajmg.a.36458
- Ishikawa Y, Vranka JA, Boudko SP, et al. Mild overmodification of collagen triple-helix structure leads to atypical osteogenesis imperfecta phenotype. J Biol Chem. 2012;287(27):22720-22730. doi:10.1074/jbc.M112.372920

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**